Inhibition of Cdk Activity
Abnormal Proliferation
Regulation of Angiogenesis and Blood Supply
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 6, 2026

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
Published on: November 5, 2014
Minhong Yan1, Christopher A Callahan, Joseph C Beyer
1Department of Tumor Biology and Angiogenesis, Genentech Inc., 1 DNA Way, South San Francisco, California 94080, USA. minhong@gene.com
Blocking Delta-like 4 (DLL4) signaling for cancer therapy may cause safety issues. Chronic blockade leads to harmful endothelial cell activation, organ disruption, and vascular tumor formation.
08:34Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
Published on: April 13, 2015
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: